Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients

Medical Mycology

Volumn 50, Issue 3, 2012, Pages 320-323

  Beser, Jessica ^a,b   Dini, Leigh ^a   Botero Kleiven, Silvia ^a   Krabbe, Margareta ^c   Lindh, Johan ^a,b   Hagblom, Per ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Department of Biology Education Centre ^*  (Sweden)

Author keywords

DHPS; Drug resistance; PCP (Pneumocystis pneumonia); Sulfa; Trimethoprim sulfamethoxazole

Indexed keywords

DIHYDROPTEROATE SYNTHASE;

ARTICLE; CONTROLLED STUDY; FUNGUS ISOLATION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PYROSEQUENCING; RETROSPECTIVE STUDY; SWEDEN; WILD TYPE;

DIHYDROPTEROATE SYNTHASE; DNA, FUNGAL; HUMANS; IMMUNOCOMPROMISED HOST; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POINT MUTATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SWEDEN;

PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

EID: 84858422506     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.593051     Document Type: Article

References (32)

1. Kovacs JA, Gill VJ, Meshnick S, Masur H. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 2001; 286: 2450-2460. (Pubitemid 33098164)
2. Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002; 34: 1098-1107. (Pubitemid 34289683)
3. Skold O. Sulfonamide resistance: mechanisms and trends. Drug Resist Updat 2000; 3: 155-160. (Pubitemid 30618026)
4. Crothers K, Beard CB, Turner J, et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 2005; 19: 801-805. (Pubitemid 40834750)
5. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lund-gren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999; 354: 1347-1351. (Pubitemid 29481631)
6. Huang L, Beard CB, Creasman J, et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis 2000; 182: 1192-1198.
7. Kazanjian P, Armstrong W, Hossler PA, et al. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000; 182: 551-557. (Pubitemid 30651053)
8. Ma L, Kovacs JA, Cargnel A, et al. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 2002; 185: 1530-1532. (Pubitemid 34507980)
9. Nahimana A, Rabodonirina M, Zanetti G, et al. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and-negative patients. J Infect Dis 2003; 188: 1017-1023. (Pubitemid 37268252)
10. Stein CR, Poole C, Kazanjian P, Meshnick SR. Sulfa use, dihy-dropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Emerg Infect Dis 2004; 10: 1760-1765. (Pubitemid 39319366)
11. Dallas WS, Gowen JE, Ray PH, Cox MJ, Dev IK. Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100. J Bacteriol 1992; 174: 5961-5970.
12. Hampele IC, D'Arcy A, Dale GE, et al. Structure and function of the dihydropteroate synthase from Staphylococcus aureus. J Mol Biol 1997; 268: 21-30. (Pubitemid 27192675)
13. Kai M, Matsuoka M, Nakata N, et al. Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene. FEMS Microbiol Lett 1999; 177: 231-235. (Pubitemid 29352218)
14. Wang P, Read M, Sims PF, Hyde JE. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol 1997; 23: 979-986. (Pubitemid 27096733)
15. Alvarez-Martinez MJ, Miro JM, Valls ME, et al. Prevalence of dihy-dropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients. Diagn Micro-biol Infect Dis 2010; 68: 60-65.
16. Alvarez-Martinez MJ, Moreno A, Miro JM, et al. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn Microbiol Infect Dis 2008; 62: 34-43.
17. Costa MC, Helweg-Larsen J, Lundgren B, Antunes F, Matos O. Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. Int J Antimicrob Agents 2003; 22: 516-520. (Pubitemid 37356953)
18. Dini L, du Plessis M, Frean J, Fernandez V. High prevalence of di-hydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J Clin Microbiol 2010; 48: 2016-2021.
19. Friaza V, Morilla R, Respaldiza N, de la Horra C, Calderon EJ. Pneu-mocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain. Postgrad Med 2010; 122: 24-28.
20. Huang L, Welsh DA, Miller RF, et al. Pneumocystis jirovecii dihy-dropteroate synthase gene mutations and human immunodeficiency virus-associated Pneumocystis pneumonia. J Eukaryot Microbiol 2006; 53 (Suppl 1): S114-116. (Pubitemid 44813351)
21. Latouche S, Lacube P, Maury E, et al. Pneumocystis jirovecii dihy-dropteroate synthase genotypes in French patients with pneumocysto-sis: a 1998-2001 prospective study. Med Mycol 2003; 41: 533-537. (Pubitemid 38075568)
22. Takahashi T, Hosoya N, Endo T, et al. Relationship between mutations in dihydropteroate synthase of Pneumocystis carini i f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol 2000; 38: 3161-3164.
23. Valerio A, Tronconi E, Mazza F, et al. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J Acquir Immune Defic Syndr 2007; 45: 521-528. (Pubitemid 47294924)
24. van Hal SJ, Gilgado F, Doyle T, et al. Clinical significance and phylo-genetic relationship of novel Australian Pneumocystis jirovecii genotypes. J Clin Microbiol 2009; 47: 1818-1823.
25. Wissmann G, Alvarez-Martinez MJ, Meshnick SR, Dihel AR, Prolla JC. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients. J Eukaryot Microbiol 2006; 53: 305-307. (Pubitemid 43990872)
26. Beard CB, Carter JL, Keely SP, et al. Genetic variation in Pneumocys-tis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000; 6: 265-272. (Pubitemid 30396382)
27. Esteves F, Montes-Cano MA, de la Horra C, et al. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect 2008; 14: 356-362. (Pubitemid 351356527)
28. Kazanjian PH, Fisk D, Armstrong W, et al. Increase in prevalence of Pneu-mocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China. J Infect Dis 2004; 189: 1684-1687. (Pubitemid 38648298)
29. Elvin KM, Bjorkman A, Linder E, Heurlin N, Hjerpe A. Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveo-lar lavage fluid by monoclonal antibodies. BMJ 1988; 297: 381-384.
30. Beser J, Botero-Kleiven S, Lebbad M, Hagblom P, Fernandez V. A limited number of ITS haplotypes defines the diversity of Pneumocys-tis jirovecii strains in Sweden. Inf Genet Evol 2011; 11: 948-954.
31. Kazanjian P, Locke AB, Hossler PA, et al. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998; 12: 873-878. (Pubitemid 28241400)
32. Smittskyddsinstitutet. homepage on the internet. Solna: Swedish Institute for Communicable Disease Control updated 2009 Sep; cited 2011 Feb 28. Available at: www.smittskyddsinstitutet.se/statistik/hivinfektion/.